{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-015986","form_type":"8-K","ticker":"CURX","cik":"0002025942","company_name":"Curanex Pharmaceuticals Inc","filed_at":"2025-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.851773+00:00","generated_at":"2026-05-17T05:28:09.223907+00:00","sec_items":["3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Curanex repays $408.5K in related-party loans, issues 28,312 shares for $200K","bullets":["Issued 28,312 shares to Xiaohong Song for $200,000 under amended subscription agreement; shares are 0.1% of total outstanding.","Prepaid $408,537.32 on two promissory notes owed to CEO's wife (Dian Ying Jing), eliminating all outstanding company debt.","Notes carried 4.34% interest with 2027 maturities; prepayment saved ~$26,183 in future interest payments."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-015986","json":"https://secwatch.observer/filing/0001493152-25-015986.json","markdown":"https://secwatch.observer/filing/0001493152-25-015986.md","text":"https://secwatch.observer/filing/0001493152-25-015986.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2025942/000149315225015986/0001493152-25-015986-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2025942/000149315225015986/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:28:09.223907+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ad6b7bae4b9b810ed014675c09ca0402c238471","claim":"Curanex Pharmaceuticals Inc issued 28,312 shares of common stock to Xiaohong Song for $200,000.","evidence_excerpt":"On September 25, 2025, Curanex Pharmaceuticals Inc, a Nevada corporation (the “Company”), issued 28,312 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) to Xiaohong Song, an investor that entered into Amended and Restated Subscription Agreement with the Company on November 27, 2024 (the “Agreement”). In accordance with the terms of the Agreement, in consideration of $200,000 subscribed for by Mr. Song, the Shares were issued following successful closing of the Company’s initial public offering (the “IPO”) on August 27, 2025","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/2025942/000149315225015986/0001493152-25-015986-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"28,312 shares"},{"label":"Purchaser","value":"Xiaohong Song"},{"label":"Consideration","value":"$200,000"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}